Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study

https://www.thelancet.com/journals/landig/article/PIIS2589-7500(24)00267-X/fulltext?dgcid=hubspot_email_infocusalerts-obgyn_feature&utm_campaign=infocusalerts-obgyn&utm_medium=email&_hsenc=p2ANqtz-9I4iahU6uuU6RUrNe0MgXiTcpf4BJK80_9wSPP1LpFHG9yWoqiycKfwHYPSXOelcvLUs9HB0vDc4JkKvQ2GY9LCn54lw&_hsmi=352424484&utm_content=352424484&utm_source=hs_email